This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Esophagus - Motility Disorders

December 19, 2019
A medium-size RCT on the growing research question of efficacy of peroral myotomy for achalasia, with a 17% failure to improve symptoms in the peroral endoscopic myotomy (POEM) arm, is discussed in this article.
October 14, 2019
Interesting sizeable series, and a commentary that follows, on what is effectively a thoracic example of Natural Orifice Transluminal Endoscopic Surgery (NOTES).
March 26, 2019
Raja and colleagues evaluated the return of symptoms and rate of reintervention following Heller myotomy for achalasia. Over a seven-year period, 248 patients underwent Heller myotomy.
December 27, 2015
The authors tested a group of 176 patients undergoing cardiac surgery for dysphagia both preoperatively and postoperatively.  Preoperatively, 8.5% of patients failed the swallow test.  Postoperatively, 21.6% failed the test.  All patients who failed preoperatively also failed postoperatively.
December 23, 2015
Intermediate term results of a single institution experience with POEM for management of achalasia are reported for the first 100 cases.  Most patients were women (59%) and the overall mean age was 48 years.  POEM was successfully completed in 94 pts and without complications.  Clinical success was declared in 94.5%, although pH studies documented ab
August 9, 2015
Case series of 500 consecutive patients undergoing POEM from September 2008 through November 2013 at a tertiary referral center in Japan.  At 2 month follow-up, the success rate was 91.3% (defined as Eckardt score < 2 or reduced > 4 points).
May 27, 2014
POEM is being increasingly used for primary treatment of achalasia.  This study evaluated POEM use for retreatment of 5 achalasia patients after prior laparoscopic esophageal myotomy and compared their results to 3 patients who underwent redo laparoscopic surgery.  Both groups had similar low complication rates and improved symptoms at intermediate-t